CLINICAL_TRIALS trial_result · 2021-06-29

Clinical Trial Update: Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer [Phase 2]

Phase 2 clinical trial evaluating Gallium-68 PSMA PET for diagnosing thyroid cancer; study terminated with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of California, San Francisco | Conditions: Thyroid Gland Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2021-06-29